Gilead CEO Takes Aim at Medicare Pricing: 'Pill Penalty' Threatens Drug Innovation
· benzinga.com · popularity 18/100 · 0 similar stories today · Retirement & Estate Planning (Money, Markets & Investing)
Read the original at benzinga.com →
Summary
Gilead Sciences Inc. (NASDAQ:GILD) stock rose Friday after the biopharmaceutical company reported better-than-expected third-quarter earnings and …
Found in: Innovation. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 11.